Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 3c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.45), $0.03 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
• Pfizer reaffirms 2026 guidance after CFO transition news